Hepatocellular Carcinoma Clinical Trials in Berlin
5 recruitingBerlin, Germany
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Gastric CancerEndometrial CancerHepatocellular Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer714 enrolled61 locationsNCT05208762
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Not Applicable
Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)
Hepatocellular Carcinoma (HCC)
Charite University, Berlin, Germany36 enrolled1 locationNCT06821958
Recruiting
Phase 3
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest434 enrolled72 locationsNCT04803994
Recruiting
The European NAFLD Registry
Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334